Exosomes secreted from M2-polarized macrophages inhibit osteoclast differentiation via CYLD

Zi-yan Guo,Nan-nan Yin,Xiao-fei Li,Meng-meng Wang,Xiao-na Sui,Cai-di Jiang,Ming-hua Xu,Xiao-e Jia,Chong-jian Fu,Tie-lou Chen,Xin Liu
DOI: https://doi.org/10.1016/j.tice.2024.102645
IF: 2.586
2024-12-05
Tissue and Cell
Abstract:Objective Bone resorption mediated by osteoclast differentiation induces the occurrence of bone-related diseases. Macrophages, an origin of osteoclasts, whose M2 type can reduce inflammation-induced bone damage. We aimed to investigate the effect of M2 macrophage-derived exosomes on osteoclast formation and elucidate its underlying mechanism. Materials and Methods Exosomes were isolated from M2 macrophages (M2-exo) and were used to treat osteoclast-like cells. Osteoclast formation was evaluated using tartrate-resistant acid phosphatase, quantitative real-time polymerase chain reaction (qRT-PCR), and Western blotting. The molecular mechanism of M2-exo function was analyzed by qRT-PCR, phosphor-kinase array analysis, and Western blotting. Results M2-exo was internalized by osteoclasts and inhibited osteoclast differentiation in vitro . Moreover, CYLD was highly expressed in M2 macrophages and M2-exo-treated osteoclasts, and knockdown of it abrogated the inhibition of osteoclast differentiation caused by M2-exo. Additionally, CYLD suppressed the phosphorylation of STAT3, and STAT3 activator colivelin reversed the inhibition of osteoclast differentiation induced by CYLD overexpression. Conclusion M2-exo inhibits osteoclast differentiation via delivering CYLD, which inactivates STAT3 signaling. These findings may provide a novel therapeutic option for bone diseases including periodontitis.
cell biology,anatomy & morphology
What problem does this paper attempt to address?